BRCA: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
New page: <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> == Function == '''BRCA1''' and '''BRCA2''' or '''breast cancer type 1 susceptibility ...
 
Michal Harel (talk | contribs)
No edit summary
 
(15 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
<StructureSection load='' size='450' side='right' caption='Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code [[3coj]]) ' scene='75/750267/Cv/4' pspeed='8'>
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>


== Function ==
== Function ==
'''BRCA1''' and '''BRCA2''' or '''breast cancer type 1 susceptibility protein''' are tumor suppressors which help repair damaged DNA.
'''BRCA1''' and '''BRCA2''' or '''breast cancer type 1 susceptibility protein''' are tumor suppressors which help repair damaged DNA.  For more details see:
*[[RING Finger Domain of BRCA1 and BARD1 Heterodimer]].
*[[Mutations in BRCA1/BARD1 RING-domain heterodimer]].
*[[Mutations in Brca1 BRCT Domains]].


== Disease ==
== Disease ==
Mutations in BRAC1 and BRAC2 are associated with increased risk of breast cancer, ovarian cancer and to a lesser extent with other cancers<ref>PMID:20301425</ref>.
Mutations in BRAC1 and BRAC2 are associated with increased risk of breast cancer, ovarian cancer and to a lesser extent with other cancers<ref>PMID:20301425</ref>.
== Relevance ==


== Structural highlights ==
== Structural highlights ==
The <scene name='75/750267/Cv/5'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>.  These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/6'>Phosphoserine binding</scene>.


==3D structures of BRCA==
[[BRCA 3D structures]]


</StructureSection>
</StructureSection>
==3D structures of BRCA1==
[[4ofb]], [[4y18]], [[4y2g]], [[4u4a]], [[4jlu]], [[4ifi]], [[4igk]], [[3k0h]], [[3k0k]], [[3coj]], [[1y98]], [[1t15]], [[1t29]], [[1t2v]] - hBRCA1 BRCT1 domain + peptide inhibitor - human<br />
[[3pxa]], [[3pxb]], [[3pxc]], [[3pxd]], [[3pxe]], [[3k15]], [[3k16]] - hBRCA1 BRCT1 domain (mutant) + peptide inhibitor<br />
[[1jnx]] - hBRCA1 BRCT domain<br />
[[2ing]], [[1t2u]], [[1n5o]] - hBRCA1 BRCT1 domain (mutant)<br />
[[1oqa]] - hBRCA1 BRCT-C domain - NMR<br />
[[1l0b]] - BRCA1 BRCT domain - rat<br />
[[2n9e]] - hBRCA1 SUMO-interacting motif + small ubiquitin-related modifier - NMR<br />
[[4mkf]], [[4mkg]] - hBRCA1 SUMO-interacting motif - NMR<br />
[[1jm7]] - hBRCA1 Ring domain + BARD1 ring domian - NMR<br />


== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]

Latest revision as of 09:58, 16 April 2019

Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code 3coj)

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman